Breiter Capital Management’s Pfizer PFE Stock Holding History

Breiter Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$432K	Sell	8,353 -1,448	-15%	-$75.1K	0.21%	89
2021 Q4	$579K	Buy	9,801 +208	+2%	+$10.3K	0.28%	77
2021 Q3	$413K	Buy	9,593 +1,009	+12%	+$44.7K	0.24%	95
2021 Q2	$336K	Buy	+8,584	New	+$334K	0.18%	110
2021 Q1	–	Sell	-9,348	Closed	-$344K	–	102
2020 Q4	$344K	Sell	9,348 -653	-7%	-$24K	0.24%	91
2020 Q3	$348K	Buy	10,001 +306	+3%	+$10.7K	0.28%	78
2020 Q2	$301K	Buy	9,695 +481	+5%	+$16.3K	0.28%	79
2020 Q1	$285K	Buy	9,214 +2,864	+45%	+$97.6K	0.34%	79
2019 Q4	$236K	Buy	+6,350	New	+$226K	0.26%	77
2019 Q3	–	Sell	-5,480	Closed	-$225K	–	86
2019 Q2	$225K	Sell	5,480 -7,779	-59%	-$309K	0.3%	74
2019 Q1	$446K	Buy	13,259 +3,321	+33%	+$133K	0.6%	62
2018 Q4	$412K	Sell	9,938 -1,906	-16%	-$79.1K	0.83%	47
2018 Q3	$495K	Sell	11,844 -1,414	-11%	-$54.4K	0.63%	58
2018 Q2	$456K	Sell	13,258 -1	-0%	-$34	0.64%	62
2018 Q1	$446K	Buy	13,259 +6,062	+84%	+$208K	0.6%	61
2017 Q4	$247K	Buy	+7,197	New	+$245K	0.36%	95

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Breiter Capital Management's PFE Position: Q1 2022 in Review

Breiter Capital Management reduced its Pfizer (PFE) stake by 15% in Q1 2022, selling an estimated $75.1K and leaving 8,353 shares worth $432K. The position accounts for 0.21% of the portfolio, ranked #89.

Breiter Capital Management first reported a position in PFE in Q4 2017 and has held it in 16 quarters since. The position peaked at $579K in Q4 2021. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

Breiter Capital Management held 8,353 shares of Pfizer worth $432K as of Q1 2022.
Breiter Capital Management sold 1,448 Pfizer shares in Q1 2022, an estimated $75.1K.
Pfizer made up 0.21% of Breiter Capital Management's portfolio in Q1 2022, its #89 holding.
Breiter Capital Management first reported a position in Pfizer in Q4 2017 and has held it in 16 quarters since.
Breiter Capital Management's Pfizer position peaked at $579K in Q4 2021.
3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Breiter Capital Management's 13F filing for Q1 2022, filed 11 May 2022.